Recover Investment Losses: Class Action Initiated Against Capricor Therapeutics, Inc. (CAPR)
Levi & Korsinsky, LLP announced that a securities class action lawsuit has been filed against Capricor Therapeutics on behalf of investors who purchased securities between December 17, 2025, and July 29, 2026. The complaint alleges the defendants made false statements regarding changes to the statistical analysis plan for lead candidate Deramiocel and misrepresented FDA approval risks.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.